避免或使用神经肌肉阻滞药对气管插管结局的影响:Cochrane系统综述
该Cochrane系统综述纳入34项随机对照试验(3565例参与者),比较避免与使用神经肌肉阻滞药(NMBA)对气管插管的影响。低偏倚风险试验显示,避免NMBA显著增加困难插管风险(RR 13.27,95%CI 8.19-21.49,P<0.00001),并增加上气道不适或损伤风险(RR=1.37,95%CI 1.09-1.74,P=0.008)。临床需权衡使用NMBA的利弊。
要点
- 避免NMBA显著增加困难气管插管风险(低偏倚风险试验RR 13.27)。
- 避免NMBA增加上气道不适或损伤风险(RR=1.37)。
- 避免NMBA与困难喉镜暴露显著相关(RR 2.54)。
核心结论
- 避免使用NMBA显著增加困难气管插管、上气道不适或损伤以及困难喉镜暴露的风险。
- 临床行气管插管时需权衡使用NMBA的利弊。
研究设计与样本
- Cochrane系统综述,检索多个数据库至2017年1月,纳入34项随机对照试验(3565例参与者),比较避免与使用NMBA的效果。
- 两名独立作者评估偏倚风险并提取数据,采用试验序贯分析(TSA)评估随机误差风险。
主要发现
- 在4项低偏倚风险试验中,避免NMBA增加困难气管插管风险(随机效应模型RR 13.27,95%CI 8.19-21.49,P<0.00001,TSA调整CI 1.85-95.04)。
- 纳入所有试验时,避免NMBA仍增加困难气管插管风险(RR 5.00,95%CI 3.49-7.15,P<0.00001,TSA调整CI 1.20-20.77)。
- 避免NMBA显著增加上气道不适或损伤风险(RR=1.37,95%CI 1.09-1.74,P=0.008,TSA调整CI 1.00-1.86)。
- 避免NMBA与困难喉镜暴露显著相关(RR 2.54,95%CI 1.53-4.21,P=0.0003,TSA调整CI 0.27-21.75)。
- 无试验报告死亡率。
临床怎么用
- 气管插管时应权衡使用NMBA的利弊,避免常规不使用NMBA。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Cohort studies have indicated that avoidance of neuromuscular blocking agents (NMBA) is a risk factor for difficult tracheal intubation. However, the impact of avoiding NMBA on tracheal intubation, possible adverse effects, and postoperative discomfort has not been evaluated in a systematic review of randomised trials. We searched several databases for trials published until January 2017. We included randomised controlled trials comparing the effect of avoiding vs using NMBA. Two independent authors assessed risk of bias and extracted data. The risk of random errors was assessed by trial sequential analysis (TSA). We included 34 trials (3565 participants). In the four trials judged to have low risk of bias, there was an increased risk of difficult tracheal intubation with no use of NMBA [random-effects model, risk ratio (RR) 13.27, 95% confidence interval (CI) 8.19-21.49, P<0.00001, TSA-adjusted CI 1.85-95.04]. The result was confirmed when including all trials, (RR 5.00, 95% CI 3.49-7.15, P<0.00001, TSA-adjusted CI 1.20-20.77). There was a significant risk of upper airway discomfort or injury by avoiding NMBA (RR=1.37, 95% CI 1.09-1.74, P=0.008, TSA-adjusted CI 1.00-1.86). None of the trials reported mortality. Avoiding NMBA was significantly associated with difficult laryngoscopy, (RR 2.54, 95% CI 1.53-4.21, P=0.0003, TSA-adjusted CI 0.27-21.75). In a clinical context, one must balance arguments for using NMBA when performing tracheal intubation.
引用
- Lundstrøm LH, Duez CHV, Nørskov AK, et al. Effects of avoidance or use of neuromuscular blocking agents on outcomes in tracheal intubation: a Cochrane systematic review. Br J Anaesth. 2018. PMID: 29793603. doi:10.1016/j.bja.2017.11.106
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。